CD38 - CD38 molecule Gene

Also Known as ADPRC 1

Species: Oryctolagus cuniculus

Gene Type: protein coding
Gene ID: 100009409

About CD38

Chromosome 2: 6,298,467-6,342,489 forward strand.OryCun2.0:CM000791.1

This gene has 2 transcripts (splice variants), 281 orthologues and 1 paralogue.

CD38 Products (1)

mRNA Protein Name
NM_001082683.1 NP_001076152.1 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1

CD38 Protein Structure

Rib_hydrolayse

Rib_hydrolayse: pfam02267 (52 - 281)

  • 0
  • 100
  • 200
  • 298 a.a.
Protein Preferred Names Protein Names

ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1

  • 2'-phospho-ADP-ribosyl cyclase

  • 2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase

  • 2'-phospho-cyclic-ADP-ribose transferase

  • ADP-ribosyl cyclase 1

  • CD38DP-ribosyl cyclase

  • cADPr hydrolase 1

  • cyclic ADP-ribose hydrolase 1

Recombinant CD38 Proteins

Cat. No. Product Name Accession Purity
HY-P72896 CD38 Protein, Rabbit (HEK293, His) Q9MZ03 (L43-M298) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9915 Daratumumab 99.10% Unkown
HY-P9976 Isatuximab Inhibitor 98.5% Unkown

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-P10563 Noraramtide / Phase 1
Inhibitory Antibodies (9)
Cat. No. Product Name Effect
Purity Phase
HY-P99616 Felzartamab Inhibitor 99.34% Phase 3
HY-P99730 Mezagitamab Inhibitor 99.76% Phase 3
HY-P9976A Isatuximab (anti-CD38) 98.44% Phase 3
HY-P991715 Sanritatug Inhibitor 99.62% Phase 3
HY-P99744 Modakafusp alfa Inhibitor 96.22% Phase 2
HY-P990037 Erzotabart Inhibitor 99.00% Phase 2
HY-P990747 Lumrotatug Inhibitor 97.00% Phase 2
HY-P991913 CID-103 Inhibitor / Phase 2
HY-P991183 SAR-442257 Inhibitor ≥99.0% Phase 1

Pre-clinical Phase

Bioactive Molecules (16)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-123999 CD38 inhibitor 1 99.83% Unkown
HY-N0640 Kuromanin chloride Inhibitor 99.83% Unkown
HY-150508 MK-0159 Inhibitor 99.72% Unkown
HY-129997 Luteolinidin chloride Inhibitor 99.91% Unkown
HY-144987 RBN013209 98.63% Unkown
HY-134358A Ara-F-NAD+ sodium Inhibitor 99.81% Unkown
HY-186178 CD38-IN-6 Inhibitor 99.96% Unkown
HY-144988 CD38 inhibitor 2 98.81% Unkown
HY-134358 Ara-F-NAD+ Inhibitor / Unkown
HY-182345 NOTA-MK0159 Inhibitor / Unkown
HY-184021 A-8531 Inhibitor / Unkown
HY-184206 A-3190 Inhibitor / Unkown
HY-171417 6-Alkyne-F-araNAD Inhibitor / Unkown
HY-181543 CVN14 Inhibitor / Unkown
HY-164628 CD38-IN-5 Inhibitor / Unkown
HY-119648A (E/Z)-CCR-11 Inhibitor 98.00% Unkown
Inhibitory Antibodies (7)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P9915A Daratumumab (Anti-CD38) 97.94% Unkown
HY-P990273 Anti-Mouse CD38 Antibody (NIMR5) Inhibitor 95.00% Unkown
HY-P991490 ISB2001 Inhibitor 99.17% Unkown
HY-P991461 AMG-424 Inhibitor 99.32% Unkown
HY-P991914 FTL004 Inhibitor / Unkown
HY-P992455 SAR442085 Inhibitor / Unkown
HY-P991462 GBR-1342 Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens CD38 NCBI NCBI:952